Optometrists in Baraga, MI Accepting Medicare
1 Optometrists found. Showing 1 - 1
 Bayview Vision Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 805 Us Highway 41 S, Suite A, Baraga, MI 49908 Phone: 906-353-8100 Fax: 906-353-8101 |
News Archive
AOBO to launch Yin Yang balancing medication Pai Du Qing Zhi Tablet
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
XACP invests $4M in $6.1M Series B financing for Health Market Science
Cross Atlantic Capital Partners announced today that it invested $4 million in a $6.1 million Series B financing for Health Market Science, a leading data and analytics provider for the healthcare industry. Cross Atlantic led the round with follow-on investments from other institutional investors, including Edison Venture Fund.
70% of oncologists and 60% of ob-gyns disagree with Task Force's mammogram recommendations
Recent recommendations by the US Preventive Task Force on Breast Cancer advising that women under the age of 50 should not get routine mammograms have resulted in fierce debate within the medical community. According to a new oncology study from ORC, an Infogroup Company, 70 percent of oncologists and 60 percent of ob-gyns disagree with the assertion that women should not get mammograms before the age of 50.
Alexza second-quarter net loss decreases to $12.9 million
Alexza Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010 and provided a business update. The net loss for the three and six months ended June 30, 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $12.9 million and $26.3 million, respectively, compared to a net loss of $17.0 million and $23.9 million in the respective comparable periods in 2009. Alexza had consolidated cash, cash equivalents and marketable securities at June 30, 2010 of $41.7 million.
Par to acquire Handa's ANDA for generic Seroquel XR
Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR.
› Verified 8 days ago